John M. Bennett

62.8k total citations · 19 hit papers
396 papers, 41.1k citations indexed

About

John M. Bennett is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, John M. Bennett has authored 396 papers receiving a total of 41.1k indexed citations (citations by other indexed papers that have themselves been cited), including 219 papers in Hematology, 116 papers in Genetics and 70 papers in Oncology. Recurrent topics in John M. Bennett's work include Acute Myeloid Leukemia Research (195 papers), Chronic Lymphocytic Leukemia Research (64 papers) and Acute Lymphoblastic Leukemia research (60 papers). John M. Bennett is often cited by papers focused on Acute Myeloid Leukemia Research (195 papers), Chronic Lymphocytic Leukemia Research (64 papers) and Acute Lymphoblastic Leukemia research (60 papers). John M. Bennett collaborates with scholars based in United States, United Kingdom and France. John M. Bennett's co-authors include Georges Flandrin, C. Sultan, Daniel Catovsky, H. R. Gralnick, D. A. G. Galton, MT Daniel, Guillermo Sanz, Peter L. Greenberg, Pierre Fenaux and Martin S. Tallman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

John M. Bennett

381 papers receiving 39.6k citations

Hit Papers

Proposals for the Classification of the Acute Leukaemias ... 1976 2026 1992 2009 1976 1997 1982 1985 2003 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group
    1976 4.5k citations John M. Bennett et al. profile →
  2. International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
    1997 3.2k citations Peter L. Greenberg, Christopher Cox et al. Blood profile →
  3. Proposals for the classification of the myelodysplastic syndromes
    1982 3.0k citations John M. Bennett et al. profile →
  4. Proposed Revised Criteria for the Classification of Acute Myeloid Leukemia
    1985 2.4k citations John M. Bennett et al. profile →
  5. Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
    2003 1.9k citations John M. Bennett, Martin S. Tallman et al. Journal of Clinical Oncology profile →
  6. Prognostic effect of weight loss prior tochemotherapy in cancer patients
    1980 1.8k citations John M. Bennett, Martin M. Oken et al. profile →
  7. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
    2009 1.8k citations Pierre Fenaux, Eva Hellström‐Lindberg et al. profile →
  8. Decitabine improves patient outcomes in myelodysplastic syndromes
    2006 1.1k citations John M. Bennett, Azra Raza et al. profile →
  9. Proposals for the classification of the myelodysplastic syndromes
    1982 993 citations John M. Bennett et al. profile →
  10. Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
    2006 893 citations Alan F. List, Gordon W. Dewald et al. profile →
  11. Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases
    1981 745 citations Richard S. Neiman, John M. Bennett et al. profile →
  12. Diagnostic criteria and classification of mastocytosis: a consensus proposal
    2001 738 citations Richard D. Brunning, John M. Bennett et al. Leukemia Research profile →
  13. Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse
    2001 654 citations Richard A. Larson, John M. Bennett et al. Journal of Clinical Oncology profile →
  14. Anthracycline Dose Intensification in Acute Myeloid Leukemia
    2009 639 citations Mark R. Litzow, Selina M. Luger et al. profile →
  15. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.
    1989 565 citations John M. Bennett et al. profile →
  16. Criteria for the Diagnosis of Acute Leukemia of Megakaryocyte Lineage (M7)
    1985 559 citations John M. Bennett et al. profile →
  17. Report of an international working group to standardize response criteria for myelodysplastic syndromes.
    2000 524 citations John M. Bennett, Guillermo Sanz et al. profile →
  18. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO)
    1991 514 citations John M. Bennett et al. profile →
  19. The Morphological Classification of Acute Lymphoblastic Leukaemia: Concordance among Observers and Clinical Correlations
    1981 385 citations John M. Bennett et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John M. Bennett United States 74 28.8k 11.5k 11.2k 8.3k 6.4k 396 41.1k
Clara D. Bloomfield United States 91 28.5k 1.0× 17.7k 1.5× 12.1k 1.1× 9.6k 1.2× 6.6k 1.0× 406 42.9k
Elihu H. Estey United States 100 27.6k 1.0× 16.0k 1.4× 8.7k 0.8× 8.7k 1.0× 8.6k 1.3× 687 39.7k
Arnold Ganser Germany 78 13.9k 0.5× 9.6k 0.8× 6.6k 0.6× 3.8k 0.5× 4.6k 0.7× 752 27.1k
James W. Vardiman United States 50 14.5k 0.5× 6.8k 0.6× 8.9k 0.8× 4.0k 0.5× 3.3k 0.5× 118 22.3k
Michael J. Borowitz United States 67 12.8k 0.4× 4.9k 0.4× 6.0k 0.5× 7.9k 1.0× 4.7k 0.7× 332 23.2k
Hartmut Döhner Germany 101 21.1k 0.7× 17.5k 1.5× 19.0k 1.7× 5.5k 0.7× 7.7k 1.2× 653 44.9k
Richard M. Stone United States 85 17.4k 0.6× 11.0k 1.0× 6.8k 0.6× 5.0k 0.6× 4.8k 0.7× 745 27.5k
Ayalew Tefferi United States 115 34.8k 1.2× 22.2k 1.9× 38.2k 3.4× 1.8k 0.2× 4.6k 0.7× 1.1k 54.7k
Donna Neuberg United States 113 12.4k 0.4× 14.4k 1.3× 9.4k 0.8× 6.0k 0.7× 14.0k 2.2× 719 46.3k
Jörge E. Cortes United States 139 60.4k 2.1× 23.6k 2.0× 41.4k 3.7× 14.6k 1.8× 15.4k 2.4× 2.3k 85.0k

Countries citing papers authored by John M. Bennett

Since Specialization
Citations

This map shows the geographic impact of John M. Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Bennett more than expected).

Fields of papers citing papers by John M. Bennett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Bennett. The network helps show where John M. Bennett may publish in the future.

Co-authorship network of co-authors of John M. Bennett

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Bennett. A scholar is included among the top collaborators of John M. Bennett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Bennett. John M. Bennett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lawlor, Claire M., et al.. (2024). Validation of a PHIS Esophageal Atresia and Tracheoesophageal Fistula Cohort in ICD‐10. Otolaryngology. 171(3). 808–814.
2.
Hussein, Siba El, et al.. (2023). Acute myelofibrosis superseding B‐lymphoblastic leukemia/lymphoma. SHILAP Revista de lepidopterología. 4(4). 1179–1181. 1 indexed citations
3.
Bennett, John M., et al.. (2023). OGC P54 Catastrophic dumping after gastrectomy in a patient with absent pituitary treated with octreotide – case report. British journal of surgery. 110(Supplement_8).
4.
Antakia, Ramez, Fanourios Georgiades, Victoria Hudson, et al.. (2021). Acute appendicitis management during the COVID-19 pandemic: A prospective cohort study from a large UK centre. International Journal of Surgery. 86. 32–37. 18 indexed citations
5.
Goasguen, J, John M. Bennett, Barbara J. Bain, et al.. (2016). Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia. Leukemia Research. 45. 75–81. 25 indexed citations
6.
Bennett, John M.. (2013). The myelodysplastic syndromes: a personal recollection of four decades of classification and prognostic scoring systems. Leukemia & lymphoma. 54(12). 2588–2591. 4 indexed citations
7.
8.
9.
10.
Flinn, Ian W., Donna Neuberg, Michael R. Grever, et al.. (2007). Phase III Trial of Fludarabine Plus Cyclophosphamide Compared With Fludarabine for Patients With Previously Untreated Chronic Lymphocytic Leukemia: US Intergroup Trial E2997. Journal of Clinical Oncology. 25(7). 793–798. 300 indexed citations
11.
Bennett, John M., et al.. (2006). Enabling adaptive management for regional natural resource management. USC Research Bank (University of the Sunshine Coast). 1 indexed citations
12.
Dutcher, Janice P., Sandra Lee, Robert J. Gallagher, et al.. (2004). Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: A study of the Eastern Cooperative Oncology Group (E1993). Leukemia & lymphoma. 46(3). 377–385. 7 indexed citations
13.
Cherry, Athena M., Stephanie R. Brockman, Sarah F. Paternoster, et al.. (2003). Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study. Leukemia Research. 27(12). 1085–1090. 54 indexed citations
14.
Tüzüner, Nükhet, Christopher Cox, Jacob M. Rowe, & John M. Bennett. (1994). Bone marrow cellularity in myeloid stem cell disorders: Impact of age correction. Leukemia Research. 18(8). 559–564. 33 indexed citations
15.
Raza, Azra, Harvey D. Preisler, George P. Browman, et al.. (1993). Long Term Outcome of Patients with Acute Myelogenous Leukemia: The Role of Maintenance Therapy, Consolidation Therapy and the Predictive Value of Twoin vitroAssays. Leukemia & lymphoma. 10(1-2). 57–66. 2 indexed citations
16.
Miller, K B, Francis S. Morrison, Jane N. Winter, et al.. (1993). The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study. Annals of Hematology. 66(3). 164–164. 91 indexed citations
17.
18.
Bennett, John M., et al.. (1981). Computers in developing nations : a one-day international seminar : proceedings of the IFIP TC-9 International Seminar on Computers in Developing Nations, Melbourne, Australia, 13 October, 1980. Elsevier eBooks. 2 indexed citations
19.
Bennett, John M.. (1977). The Australian Computer Society.. Australian Computer Journal. 9. 7–8. 12 indexed citations
20.
Bennett, John M. & E Henderson. (1969). Lymphoblastic leukaemia.. BMJ. 2(5655). 513.2–513. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clara D. Bloomfield Breakdown of academic impact, for papers by Elihu H. Estey Breakdown of academic impact, for papers by Arnold Ganser Breakdown of academic impact, for papers by James W. Vardiman Breakdown of academic impact, for papers by Michael J. Borowitz Breakdown of academic impact, for papers by Hartmut Döhner Breakdown of academic impact, for papers by Richard M. Stone Breakdown of academic impact, for papers by Ayalew Tefferi Breakdown of academic impact, for papers by Donna Neuberg Breakdown of academic impact, for papers by Jörge E. Cortes
Rankless by CCL
2026